The role of dual tracer PSMA and [18F]FDG PET/CT in primary renal tumors
Nuclear Medicine Review · 2026
DOI: 10.5603/nmr.113240 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nuclear Medicine Review, 2026. Verfasst von Tarik Sengoz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Pamukkale University, Medical Faculty, Department of Nuclear Medicine, Denizli, Turkiye. tsengoz@pau.edu.tr. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Fluorodeoxyglucose F18, Kidney Neoplasms, Glutamate Carboxypeptidase II.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pamukkale University, Medical Faculty, Department of Nuclear Medicine, Denizli, Turkiye. tsengoz@pau.edu.tr.
- Denizli State Hospital, Department of Nuclear Medicine, Denizli, Turkiye.
- Pamukkale University, Medical Faculty, Department of Urology, Denizli, Turkiye.
ORCID-Profile: Tarik Sengoz, Merve Yucel Kahraman
Zitieren
APA
Sengoz, T., Kahraman, M. Y., Ozlulerden, Y., & Celen, S. (2026). The role of dual tracer PSMA and [18F]FDG PET/CT in primary renal tumors. Nuclear Medicine Review. https://doi.org/10.5603/nmr.113240
Vancouver
Sengoz T, Kahraman MY, Ozlulerden Y, Celen S. The role of dual tracer PSMA and [18F]FDG PET/CT in primary renal tumors. Nuclear Medicine Review. 2026. doi:10.5603/nmr.113240
BibTeX
@article{Sengoz2026,
author = {Sengoz, Tarik and Kahraman, Merve Yucel and Ozlulerden, Yusuf and Celen, Sinan},
title = {The role of dual tracer PSMA and [18F]FDG PET/CT in primary renal tumors},
journal = {Nuclear Medicine Review},
year = {2026},
doi = {10.5603/nmr.113240}
}
EUVIMED